The role of neck dissection following definitive chemoradiation

ONCOLOGY

Volumn 18, Issue 8, 2004, Pages 993-998

  Kutler, David I ^a   Patel, Snehal G ^b   Shah, Jatin P ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; HEAD AND NECK TUMOR; HUMAN; LYMPH NODE METASTASIS; NECK DISSECTION; PATHOLOGY; PATIENT CARE PLANNING; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

DECISION MAKING; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NECK DISSECTION; PATIENT CARE PLANNING; PROGNOSIS; TREATMENT OUTCOME;

EID: 5144231863     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Taylor SG, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck-cancer. J Clin Oncol 12:385-395, 1994.
2. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999.
3. Adelstein DJ, Li Y, Adams GL, et al: Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98, 2003.
4. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997.
5. Al Sarraf M: Editorial comment: Improving the cure rate and overall survival of patients with nasopharyngeal cancers by improving the systemic chemotherapy. Head Neck 25:447-450, 2003.
6. Barkley HT, Fletcher GH, Jessee RH, et al: Managment of cervical lymph node metastases in squamous cell carcinomas of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124:462-467, 1972.
7. Armstrong J, Pfister D, Strong E, et al: The management of the clinically positive neck as part of a larynx preservation approach, Int J Radiat Oncol Biol Phys 26:759-765, 1993.
8. Wolf GT, Fisher SG: Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 102:934-939, 1992.
9. Weisman RA, Robbins KT: Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am 3:773, 1998.
10. Narayan K, Crane CH, Kleid S, et al: Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: For some or for all? Head Neck 21:606-613, 1999.
11. Parsons JT, Mendenhall WM, Stringer SP, et al: Squamous cell carcinoma of the oropharynx: Surgery, radiation therapy or both. Cancer 94:2967-2980, 2002.
12. Dubray BM, Bataini JP, Bernier J, et al: Is reseeding from the primary a plausible cause of node failure. Int J Radiat Oncol Biol Phys 25:9-15, 1993.
13. McHamm SA, Adelstein DJ, Rybicki LA, et al: Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 25:791-798, 2003.
14. Stenson KM, Haraf DJ, Pelzer H, et al: The role of cervical lymphadenectomy after aggressive concomitant chemaradiotherapy - the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 126:950-956, 2000.
15. Wanebo H, Chougule P, Ready N, et al: Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 8:644-650, 2001.
16. Lavertu P, Adelstein DJ, Saxton JP, et al: Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 19:559-566, 1997.
17. Koch WM, Lee DJ, Eisele DW, et al: Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 121:974-980, 1995.
18. Lavertu P, Bonafede JP, Adelstein DJ, et al: Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 124:401-406, 1998.
19. Wang SJ, Wang MB, Calcaterra TC: Radiotherapy followed by neck dissection for small head and neck cancers with advanced cervical metastases. Ann Otol Rhinol Laryngol 108:128-131, 1999.
20. Dagum P, Pinto HA, Newman JP, et al: Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 176:448-452, 1998.
21. Strasser MD, Gleich LL, Miller MA, et al: Management implications of evaluating the N2 and N3 neck after organ preservation therapy. Laryngoscope 109:1776-1780, 1999.
22. Newman JP, Terris DJ, Pinto HA, et al: Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Ann Otol Rhinol Laryngol 106:117-122, 1997.
23. Wong RJ, Lin DT, Schoder H, et al: Diagnostic and prognostic value of [F-18]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20:4199-4208, 2002.
24. Schechter NR, Gillenwater AM, Byers RM, et al: Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys 51:4-9, 2001.
25. Greven KM, Williams DW, McGuirt WF, et al: Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23:942-946, 2001.
26. Fortin A, Raybaud-Diogene H, Tetu B, et al: Markers of neck failure in oral cavity and oropharyngeal carcinomas treated with radiotherapy. Head Neck 23:87-93, 2001.
27. Mabanta SR, Mendenhall WM, Stringer SP, et al: Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 21:591-594, 1999.
28. Mendenhall WM, Million RR, Cassisi NJ: Squamous-cell carcinoma of the head and neck treated with radiation therapy - the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12:733-740, 1986.
29. Robbins KT, Wong FSH, Kumar P, et al: Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125:670-675, 1999.